NCT05073484View on ClinicalTrials.gov

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

PHASE1TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 29, 2021

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2023

Conditions
Advanced Solid Tumor
Interventions
DRUG

BAT6021

Ⅳ infusions

DRUG

BAT1308

Ⅳ infusions

Trial Locations (3)

Unknown

Liverpool Hospital, Liverpool

Macquarie University Hospital, Sydney

Cabrini Hospital Malvern, Melbourne

Sponsors
All Listed Sponsors
lead

Bio-Thera Solutions

INDUSTRY